Atlas Trials

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

Clinical trial NCT03570346 · UNKNOWN

Trial details

NCT number
NCT03570346
Sponsor
Tianjin Hemay Bio-Tech Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis
Start date
2018-07-10
Primary completion
2018-10-20
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.